Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

top border
top border
Featured Programs
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now
Post-Transplant TMA: Survival with MASP-2 Inhibitors
Vincent T. Ho, MD, of Dana-Farber Cancer Institute, discusses data from a phase II study of narsoplimab in patients with transplant-associated, post-transplant thrombotic microangiopathy (TMA). View Now
Featured Video
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
Christina Tan, MD, MPH, state epidemiologist, assistant commissioner, New Jersey Department of Health, discusses the potential impact of the novel coronavirus on patients with cancer. View now
Gina Columbus

Gina Columbus recaps some of the top news presented each day during the 2020 Transplantation & Cellular Therapy Meetings.

Publication Bottom Border
Border Publication
x